obesity drug news today october 2025 glp-1 The FDA approved a pill version of the receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 From evidence to action: WHO

Optum Now does not provide medical advice, diagnosis, or treatment.

In response to the growing trend of preventive healthcare, companies are launching specialized carnitine supplements that support energy production and fat metabolism to enhance physical fitness and overall health

We are thrilled to have the support of a syndicate that truly believes in our vision to transform orthodontics, said KLOwen Orthodontics CEO, Ryan Elmore

Neuronal activity-dependent cell survival mediated by transcription factor MEF2

Glutathione is a tripeptide entity commonly described in biochemical literature through glutamate, cysteine, and glycine structure context [3]